Phase 1 Poliomyelitis Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
Poliomyelitis
CanSino Biologics Inc.480 enrolled1 locationNCT06577298
Recruiting
Phase 1Phase 2
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
Poliomyelitis
PATH2,400 enrolled2 locationsNCT06137664
Not Yet Recruiting
Phase 1
Safety and immune response of polio vaccines in healthy adults
Poliomyelitis
World Health Organization30 enrolled1 locationACTRN12612000465853